Axsome Therapeutics Inc (AXSM) with a beta value of 1.11 appears to be a promising investment opportunity.
Axsome Therapeutics Inc (NASDAQ: AXSM) kicked off on Friday, down -3.60% from the previous trading day, before settling in for the closing price of $71.73.